Stockreport

Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China

Ascendis Pharma A/S - American Depositary Shares  (ASND) 
Last ascendis pharma a/s - american depositary shares earnings: 11/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ascendispharma.com
PDF - 50/50 joint venture with investor syndicate led by Vivo Capital – - Expands global reach for TransCon products  – COPENHAGEN, Denmark, Nov. 08, 2018 (GLOBE NEWSWI [Read more]